nivocasan

Nivocasan, also known as GS-9450 and LB-84451, a novel caspase-inhibitor has demonstrated hepatoprotective activity in fibrosis apoptosis animal models. GS-9450 treatment induced significant reductions in ALT levels in NASH patients.

Nivocasan Intermediate是一种Nivocasan的中间体。Nivocasan(GS-9450)是一种泛caspase抑制剂，可用于研究HCV感染和非酒精性脂肪性肝炎。